Dapeng Zhou

7PUBLICATIONS
1CO-AUTHORS
Innate immunityMedical molecular engineering of nucleic acids and proteinsPredictive and prognostic markersGlycoconjugatesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 03, 2021
Potent Neutralization Antibodies Induced by a Recombinant Trimeric Spike Protein Vaccine Candidate Containing PIKA Adjuvant for COVID-19.

Jiao Tong, Chenxi Zhu, Hanyu Lai

|Oct 21, 2020
An antibody-drug conjugate targeting a GSTA glycosite-signature epitope of MUC1 expressed by non-small cell lung cancer.

Deng Pan, Yubo Tang, Jiao Tong

|Nov 15, 2019
Immunogenicity of Del19 EGFR mutations in Chinese patients affected by lung adenocarcinoma.

Deng Pan, Dapeng Zhou, Weijing Cai

|Oct 29, 2019
Separation and detection of minimal length glycopeptide neoantigen epitopes centering the GSTA region of MUC1 by liquid chromatography/mass spectrometry.

Dapeng Zhou, Kaijie Xiao, Zhixin Tian

|Jan 17, 2019
Preferential Localization of MUC1 Glycoprotein in Exosomes Secreted by Non-Small Cell Lung Carcinoma Cells.

Deng Pan, Jiaxi Chen, Chunchao Feng

|Aug 05, 2018
MHC class II restricted neoantigen peptides predicted by clonal mutation analysis in lung adenocarcinoma patients: implications on prognostic immunological biomarker and vaccine design.

Weijing Cai, Dapeng Zhou, Weibo Wu

Pageof 2

Frequent Collaborators

1 joint publications

Zhixin Tian